FDA
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada
-
-
-
-
-
-
-
Fennec Pharmaceuticals announces public offering of common shares
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director
-
333,137 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


